Diabetes Control and Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practiced in the
Diabetes Control and Complications Trial. JAMA.1996;276:1409-1415.
Eastman RC, Javitt JC, Herman WH.
et al. Model of complications of NIDDM, I: model construction and assumptions. Diabetes Care.1997;20:725-734.
Eastman RC, Javitt JC, Herman WH.
et al. Model of complications of NIDDM, II: analysis of the health benefits
and cost-effectiveness of treating NIDDM with the goal of normo-glycemia. Diabetes Care.1997;20:735-744.
Gilmer TP, O'Connor PJ, Manning WG, Rush WA. The cost to health plans of poor glycemic control. Diabetes Care.1997;20:1847-1853.
Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycemic
control in patients with type 2 diabetes mellitus: a randomized, controlled,
double-blind trial. JAMA.1998;280:1490-1496.
Clark CM, Fradkin JE, Hiss RG, Lorenz PA, Vinicor F, Warren-Boulton E. Promoting early diagnosis and treatment of type 2 diabetes: the National
Diabetes Education Program. JAMA.2000;284:363-364.
McCulloch KD, Price MJ, Hindmarsh M, Wagner EH. A population-based approach to diabetes management in a primary care
setting: early results and lessons learned. Eff Clin Pract.1998;1:12-22.
Aubert RE, Herman WH, Waters J.
et al. Nurse case management to improve glycemic control in diabetic patients
in a health maintenance organization: a randomized, controlled trial. Ann Intern Med.1998;129:605-612.
Peters AL, Davidson MB, Ossorio RL. Management of patients with diabetes by nurses with support of subspecialists. HMO Pract.1995;9:8-13.
Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Wagner EH. Patient-level estimates of the cost of complications in diabetes in
a managed-care population. Pharmacoeconomics.1999;16:285-295.
Newton KM, Wagner EH, Ramsey SD.
et al. The use of automated data to identify complications and comorbidities
of diabetes: a validation study. J Clin Epidemiol.1999;52:199-207.
Fishman P, Von Korff M, Lozano P, Hecht J. Chronic care costs in managed care: the first single-plan comparison
of chronic care costs shows why cost-effective clinical approaches are critical
to managed care success. Health Aff (Millwood).1997;16:239-247.
Ramsey SD, Newton K, Blough D.
et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care.1999;22:382-387.
Duan N. Smearing estimate: a nonparametric retransformation method. J Am Stat Assoc.1983;78:605-610.
Rutten-van Molken MP, van Doorslaer EK, van Vliet RC. Statistical analysis of cost outcomes in a randomized controlled clinical
trial. Health Econ.1994;3:333-345.
Diabetes Control and Complications Trial Research Group. Resource utilization and costs of care in the Diabetes Control and
Complications Trial. Diabetes Care.1995;18:1468-1478.
O'Connor PJ, Crabtree BF, Abourizk NN. Longitudinal study of a diabetes education and care intervention: predictors
of improved glycemic control. J Am Board Fam Pract.1992;5:381-387.
Wagner EH, Curry SJ, Grothaus L, Saunders KW, McBride CM. The impact of smoking and quitting on health care use. Arch Intern Med.1995;155:1789-1795.
Hayward RA, Manning WG, Kaplan SH, Wagner EH, Greenfield S. Starting insulin therapy in patients with type 2 diabetes: effectiveness,
complications, and resource utilization. JAMA.1997;278:1663-1669.
Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q.1996;74:511-544.
Wagner EH. More than a case manager. Ann Intern Med.1998;129:654-656.